[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 770 Agreed to Senate (ATS)]

<DOC>






119th CONGRESS
  2d Session
S. RES. 770

     Designating June 6, 2026, as National Naloxone Awareness Day.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             June 15, 2026

   Mr. Scott of Florida (for himself, Mr. Markey, Ms. Cantwell, Mr. 
Tillis, Mr. Blumenthal, Mrs. Capito, Mr. Whitehouse, Ms. Klobuchar, Mr. 
 Risch, Mr. King, Mr. Heinrich, Mr. Wyden, Mr. Booker, Mr. Bennet, Mr. 
Lankford, Mrs. Moody, Mr. Justice, and Ms. Cortez Masto) submitted the 
        following resolution; which was considered and agreed to

_______________________________________________________________________

                               RESOLUTION


 
     Designating June 6, 2026, as National Naloxone Awareness Day.

Whereas opioid overdoses continue to devastate communities across the United 
        States, leading to a significant loss of life and widespread societal 
        impact;
Whereas opioid overdoses during the 12 months preceding November of 2025 claimed 
        a reported 43,810 lives in the United States;
Whereas fatal overdoses are often witnessed by a bystander;
Whereas, in 2025 alone, the Drug Enforcement Administration seized more than 
        369,000,000 potentially deadly doses of fentanyl, enough to kill every 
        individual in the United States;
Whereas, according to data from the Centers for Disease Control and Prevention, 
        fentanyl-related poisonings are a leading cause of death for individuals 
        in the United States between 18 and 44 years of age;
Whereas naloxone is a safe and effective medication that can reverse opioid 
        overdoses and save lives when administered promptly by rapidly reversing 
        the effects of opioids;
Whereas naloxone plays a vital role in preventing long-term brain damage and 
        reducing the risk of fatality associated with opioid overdoses;
Whereas the Centers for Disease Control and Prevention recognizes naloxone as an 
        important tool in preventing opioid overdose deaths;
Whereas it is imperative to educate individuals, families, healthcare 
        professionals, and first responders about--

    (1) the benefits of naloxone, including the potential naloxone has to 
reduce opioid-related fatalities; and

    (2) how to safely administer naloxone;

Whereas it is imperative to identify current or potential barriers for 
        individuals, organizations, and Federal, State, and local governments to 
        obtain and distribute naloxone;
Whereas increasing access to naloxone can improve the chances of recovery for 
        individuals struggling with opioid use disorder and support a future 
        free from the grip of opioid use disorder;
Whereas the Food and Drug Administration acted to authorize the over-the-counter 
        sale of 10 milligram doses of naloxone alongside extending the shelf 
        life of newly manufactured naloxone 4 milligram nasal spray products 
        from 3 to 4 years in 2024; and
Whereas recognizing National Naloxone Awareness Day will contribute to the 
        ongoing efforts to educate the public, reduce the stigma associated with 
        substance use disorder, and promote access to lifesaving naloxone: Now, 
        therefore, be it
    Resolved, That the Senate--
            (1) designates June 6, 2026, as National Naloxone Awareness 
        Day;
            (2) recognizes the life-saving benefits of naloxone in 
        reversing opioid overdoses and preventing unnecessary deaths;
            (3) acknowledges that increased access to naloxone empowers 
        individuals, families, healthcare professionals, and first 
        responders to intervene in emergency situations and provide 
        immediate assistance to those experiencing an opioid overdose;
            (4) recognizes that National Naloxone Awareness Day serves 
        as an opportunity to educate the public about the importance of 
        recognizing the signs of opioid overdose and equipping 
        themselves with naloxone to save lives;
            (5) encourages Federal, State, and local governments, as 
        well as private and nonprofit organizations, to support 
        increased naloxone access, education, and distribution efforts; 
        and
            (6) calls upon Federal agencies, including the Substance 
        Abuse and Mental Health Services Administration, the Centers 
        for Disease Control and Prevention, the Office of National Drug 
        Control Policy, the Drug Enforcement Administration, and all 
        others engaged in the National Drug Control Strategy to 
        continue supporting public awareness of naloxone, and overdose 
        and poisoning prevention.
                                 <all>